Overview

Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity

Status:
Not yet recruiting
Trial end date:
2023-10-23
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerability of AMG 786 as single or multiple doses in healthy and obese participants.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen